Sept 10 (Reuters) - Mesoblast Ltd MSB.AX :
* GRÜNENTHAL, CO ENTER STRATEGIC PARTNERSHIP FOR EUROPE , LATIN AMERICA TO DEVELOP, CELL THERAPY FOR TREATMENT OF CHRONIC LOW BACK PAIN
* MESOBLAST WILL RECEIVE UP TO US$150 MILLION IN UPFRONT AND MILESTONE PAYMENTS PRIOR TO PRODUCT LAUNCH